Gilead Withdraws Request for Special Orphan Status on Experimental Coronavirus Treatment

Critics said the company was profiteering from the coronavirus pandemic by seeking tax and monopoly benefits under a program intended to encourage drug development for rare diseases.
Source: NYT Health - Category: Consumer Health News Authors: Tags: Drugs (Pharmaceuticals) Gilead Sciences Inc Food and Drug Administration Remdesivir (Drug) your-feed-healthcare Coronavirus (2019-nCoV) Source Type: news